![](https://endpts.com/wp-content/uploads/2023/12/Elizabeth-Mily-Bristol-Myers-JPM23-tile.jpg)
Elizabeth Mily at #JPM23 (Adrien Villez for Endpoints News)
Bristol Myers’ lead deal negotiator to depart after inking series of multibillion-dollar acquisitions
Elizabeth Mily, the lead acquisition and deal negotiator at Bristol Myers Squibb, is leaving the Big Pharma, a spokesperson confirmed to Endpoints News on Friday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.